Connect with journalists.
Sponsored
Founder
San Francisco, CA, USA
I track GLP-1 medication outcomes through regular DEXA scans, comparing body composition changes across 50+ telehealth providers. I run ClearMetabolic.com, where I publish evidence-based GLP-1 research citing trials from NEJM, Obesity Reviews, and PubMed. Former McKinsey consultant and start up executive. Diagnosed with type 2 diabetes at 38, currently on tirzepatide.